Endra Life Sciences . Warrants Stock News

Endra Life Sciences <> said the U.S. Patent and Trademark Office issued a new patent related to the company''s Thermo Acoustic Enhanced UltraSound ((TAEUS)) system.TAEUS is…

ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the European Patent Office (EPO) has issued two new patents to ENDRA, European Patent No. 3668382 (the ‘382 patent) titled “Method and System for Estimating Fractional Fat Content of an Object” and European Patent No. 3661416 (the ‘416 patent) titled “Method for Estimating Fractional Fat Content of an Object.” The ‘382 patent protects ENDRA''s meth

ENDRA Life Sciences Inc (NASDAQ: NDRA ) plans to voluntarily withdraw its 510(k) application , currently under FDA review for its TAEUS System. Instead, the Company will subsequently submit a De Novo application. TAEUS is initially focused on measuring fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Full story available on Benzinga.com

ENDRA Life Sciences Inc. (NASDAQ:NDRA) with the stream of 6.79% also noticed, India Tanzanian Gold Corporation (AMEX:TRX) encountered a rapid change of -4.18% in the last hour of Thursdays trading The post Traders should follow this: ENDRA Life Sciences Inc. (NASDAQ:NDRA), Tanzanian Gold Corporation (AMEX:TRX) appeared first on Stocks Equity .

Zacks Investment Research lowered shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a research note issued to investors on Saturday morning, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. []

Goldman Sachs Group Inc. acquired a new position in ENDRA Life Sciences Inc. (NASDAQ:NDRA) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 47,709 shares of the companys stock, valued at approximately $104,000. Goldman Sachs Group Inc. owned 0.11% of ENDRA Life Sciences at []

ENDRA Life Sciences (NASDAQ:NDRA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Saturday, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. NASDAQ NDRA []

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 The post Tips For Effortless money: Ardelyx, Inc. (NASDAQ:ARDX 12.86%), ENDRA Life Sciences Inc. (NASDAQ:NDRA -4.84%) appeared first on Stocks Equity .

In the last trading session, 1.15 million ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares changed hands as the company’s beta touched 1.24. With the company’s per share price at $0.87 changed hands at $0.07 or 8.31% during last session, the market valuation stood at $38.53M. NDRA’s last price was a discount, traded about -256.32% off its … ENDRA Life Sciences Inc. (NASDAQ: NDRA): Don’t Ditch NDRA Stock In 2021 Read More »

Zacks Investment Research upgraded shares of ENDRA Life Sciences (NASDAQ:NDRA) from a hold rating to a buy rating in a report issued on Monday morning, Zacks.com reports. They currently have $1.00 target price on the stock. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is []

ANN ARBOR, Mich. & SYDNEY--(BUSINESS WIRE)--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), and VGI Health Technology Limited (NSX: VTL), a clinical-stage biotechnology company specializing in developing and commercializing evidence-based nutraceuticals and pharmaceuticals, announce today the signing of a collaboration agreement to incorporate ENDRAs proprietary TAEUS technology to support patient screening and biomarker measurement during VG

ADM Tronics Unlimited (OTCMKTS:ADMT) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, institutional ownership and risk. Earnings & Valuation This table compares ADM Tronics Unlimited and ENDRA Life Sciences []

ENDRA Life Sciences (NASDAQ:NDRA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. Shares of []

Zacks Investment Research downgraded shares of ENDRA Life Sciences (NASDAQ:NDRA) from a buy rating to a hold rating in a report published on Wednesday, Zacks.com reports. According to Zacks, “ENDRA Life Sciences Inc. is a developer of enhanced ultrasound technologies. ENDRA Life Sciences Inc. is based in Ann Arbor, United States. “ Shares of NDRA […]

Citius Pharmaceuticals, Inc. (CTXR) with the stream of -2.05% also noticed, India ENDRA Life Sciences Inc. (NDRA) encountered a rapid change of -9.11% in the last hour of Monday’s trading … The post Up to Date Stock in Review: Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), ENDRA Life Sciences Inc. (NASDAQ:NDRA) appeared first on Stocks Equity .